webinar: hereditary cancer risk assessment – benefit vs. cost in precision medicine
Published 4 years ago • 59 plays • Length 37:05Download video MP4
Download video MP3
Similar videos
-
1:02:22
webinar: precision medicine in oncology
-
42:52
webinar: role of pharmacogenetic testing in personalized medicine
-
56:48
webinar: detection of therapeutically targetable mutations in nsclc
-
42:05
webinar: novel approach for multiplex ultrasensitive detection
-
2:03:18
precision medicine seminar series part 1
-
48:30
melanoma and the role of personalized medicine: a dermatologist/dermatopathologist’s perspective
-
1:00:41
webinar: pgx testing developments and future directions
-
1:20
advanced risk assessment and genetic testing with the lake health cancer prevention center
-
1:32:00
living with nasopharyngeal cancer (npc)
-
3:45:16
abc oncology educational course 2021 - hematological cancers module - session iii
-
1:34:26
liquid biopsy in lung disease
-
1:00:10
webinar: the promise of liquid biopsy for individualizing cancer care
-
1:25:28
a webinar on precision oncology biomarkers by bis research
-
18:14
precision cancer medicine | professor andrew biankin
-
3:09
precision medicine in gastrointestinal cancers: promise and pitfalls
-
1:01:36
webinar: detection of medulloblastoma-associated dna methylation patterns
-
1:06:42
gene mutations and precision cancer medicine - webinar - june 27, 2022
-
2:28:07
abc oncology educational course 2021 - precision medicine module - session ii
-
5:00
breast cancer: identification & pharmacologic management of high-risk patients
-
4:17
the promise of precision medicine
-
1:04:42
webinar: pgx-guided pharmacotherapy: recent developments & implementation in clinical practice
-
1:55
cancer research policy forum: progress, promise, and challenges in the era of precision medicine